Covid-19 prevalence, disease course, and impact on pulmonary outcome in a TB cohort in four African countries (Covid-19_TB)
- Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
- Total publications:0 publications
Grant number: 01KI20390
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$57,564Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)Principal Investigator
PD Dr med Andrea RachowResearch Location
Mozambique, Gambia…Lead Research Institution
Ludwig-Maximilians-Universität MünchenResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Other
Occupations of Interest
Unspecified
Abstract
The aim of the project is to examine the effects of Covid 19 disease on tuberculosis patients in four African countries (Gambia, Mozambique, South Africa and Tanzania). For this purpose, appropriate clinical data are collected and analyzed on site. The frequency of the diseases and other epidemiological parameters of the SARS-CoV-2 infection as well as the clinical characteristics of the Covid-19 disease are to be described and compared with other patient groups and the healthy population. In addition, the interrelationship between pulmonary tuberculosis (and chronic lung disease after TB) and Covid-19 in terms of the severity and severity of both diseases is the subject of the project. The work is flanked by questions relating to social science aspects.